AI Article Synopsis

  • This study investigates the use of artificial intelligence (AI) in CT imaging to quantify pneumonia severity in COVID-19 patients and its ability to predict critical outcomes and lung complications.
  • A total of 1,200 hospitalized COVID-19 patients were assessed, revealing that those with a higher percentage of lung lesions experienced significantly worse outcomes, such as the need for intensive oxygen support and higher mortality rates.
  • Follow-up scans showed that patients with more severe pneumonia at admission and other factors like age and sex contributed further to the risk of ongoing lung issues post-discharge.

Article Abstract

Background: Computed tomography (CT) imaging and artificial intelligence (AI)-based analyses have aided in the diagnosis and prediction of the severity of COVID-19. However, the potential of AI-based CT quantification of pneumonia in assessing patients with COVID-19 has not yet been fully explored. This study aimed to investigate the potential of AI-based CT quantification of COVID-19 pneumonia to predict the critical outcomes and clinical characteristics of patients with residual lung lesions.

Methods: This retrospective cohort study included 1,200 hospitalized patients with COVID-19 from four hospitals. The incidence of critical outcomes (requiring the support of high-flow oxygen or invasive mechanical ventilation or death) and complications during hospitalization (bacterial infection, renal failure, heart failure, thromboembolism, and liver dysfunction) was compared between the groups of pneumonia with high/low-percentage lung lesions, based on AI-based CT quantification. Additionally, 198 patients underwent CT scans 3 months after admission to analyze prognostic factors for residual lung lesions.

Results: The pneumonia group with a high percentage of lung lesions (N = 400) had a higher incidence of critical outcomes and complications during hospitalization than the low percentage group (N = 800). Multivariable analysis demonstrated that AI-based CT quantification of pneumonia was independently associated with critical outcomes (adjusted odds ratio [aOR] 10.5, 95% confidence interval [CI] 5.59-19.7), as well as with oxygen requirement (aOR 6.35, 95% CI 4.60-8.76), IMV requirement (aOR 7.73, 95% CI 2.52-23.7), and mortality rate (aOR 6.46, 95% CI 1.87-22.3). Among patients with follow-up CT scans (N = 198), the multivariable analysis revealed that the pneumonia group with a high percentage of lung lesions on admission (aOR 4.74, 95% CI 2.36-9.52), older age (aOR 2.53, 95% CI 1.16-5.51), female sex (aOR 2.41, 95% CI 1.13-5.11), and medical history of hypertension (aOR 2.22, 95% CI 1.09-4.50) independently predicted persistent residual lung lesions.

Conclusions: AI-based CT quantification of pneumonia provides valuable information beyond qualitative evaluation by physicians, enabling the prediction of critical outcomes and residual lung lesions in patients with COVID-19.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552312PMC
http://dx.doi.org/10.1186/s12931-023-02530-2DOI Listing

Publication Analysis

Top Keywords

ai-based quantification
20
critical outcomes
20
residual lung
16
lung lesions
16
quantification pneumonia
12
patients covid-19
12
pneumonia
8
covid-19 pneumonia
8
computed tomography
8
retrospective cohort
8

Similar Publications

Unlabelled: Accurate assessment of shoulder range of motion (ROM) is crucial for evaluating patient progress. Traditional manual goniometry often lacks precision and is subject to inter-observer variability, especially in measuring shoulder internal rotation (IR). This study introduces an artificial intelligence (AI)-based approach that uses clinical photography to improve the accuracy of ROM quantification.

View Article and Find Full Text PDF

Purpose: The purpose of this study is to present a correlative microscopy-tomography approach in conjunction with machine learning-based image segmentation techniques, with the goal of enabling quantitative structural and compositional elucidation of real-world pharmaceutical tablets.

Methods: Specifically, the approach involves three sequential steps: 1) user-oriented tablet constituent identification and characterization using correlative mosaic field-of-view SEM and energy dispersive X-ray spectroscopy techniques, 2) phase contrast synchrotron X-ray micro-computed tomography (SyncCT) characterization of a large, representative volume of the tablet, and 3) constituent segmentation and quantification of the imaging data through user-guided, iterative supervised machine learning and deep learning.

Results: This approach was implemented on a real-world tablet containing 15% API and multiple common excipients.

View Article and Find Full Text PDF

Objective: To evaluate the repeatability of AI-based automatic measurement of vertebral and cardiovascular markers on low-dose chest CT.

Methods: We included participants of the population-based Imaging in Lifelines (ImaLife) study with low-dose chest CT at baseline and 3-4 month follow-up. An AI system (AI-Rad Companion chest CT prototype) performed automatic segmentation and quantification of vertebral height and density, aortic diameters, heart volume (cardiac chambers plus pericardial fat), and coronary artery calcium volume (CACV).

View Article and Find Full Text PDF
Article Synopsis
  • The rising incidence of cancer has created a pressing need for improved early detection tools, highlighting the importance of identifying specific biomarkers for accurate diagnosis.
  • Cancer-derived small extracellular vesicles (sEVs) have emerged as a promising biomarker, given their abundance in body fluids and their rich assortment of biological indicators.
  • Surface-enhanced Raman scattering (SERS) technology is gaining traction for its ability to quickly and sensitively detect cancer sEVs using various innovative assays, paving the way for enhanced early detection and classification of cancers in clinical settings.
View Article and Find Full Text PDF

This retrospective study developed an automated algorithm for 3D segmentation of adipose tissue and paravertebral muscle on chest CT using artificial intelligence (AI) and assessed its feasibility. The study included patients from the Boston Lung Cancer Study (2000-2011). For adipose tissue quantification, 77 patients were included, while 245 were used for muscle quantification.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!